Italy Perfusion Systems Market Size & Outlook, 2023-2030
- MedTech
- General Surgery
- Perfusion Systems Market Outlook
- General Surgery
Italy Perfusion Systems Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask a question about the perfusion systems market
Italy perfusion systems market highlights
- The Italy perfusion systems market generated a revenue of USD 24.1 million in 2023 and is expected to reach USD 29.9 million by 2030.
- The Italy market is expected to grow at a CAGR of 3.2% from 2024 to 2030.
- In terms of segment, cardiopulmonary perfusion system was the largest revenue generating application in 2023.
- Cardiopulmonary Perfusion System is the most lucrative application segment registering the fastest growth during the forecast period.
Perfusion systems market data book summary
| Market revenue in 2023 | USD 24.1 million |
| Market revenue in 2030 | USD 29.9 million |
| Growth rate | 3.2% (CAGR from 2023 to 2030) |
| Largest segment | Cardiopulmonary perfusion system |
| Fastest growing segment | Cardiopulmonary Perfusion System |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
| Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
Other key industry trends
- In terms of revenue, Italy accounted for 2.2% of the global perfusion systems market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK perfusion systems market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 88.3 million by 2030.
Italy’s aging population and the growing proportion of individuals aged over 65 years are some of the key factors expected to drive the perfusion systems market. This demographic shift is significant as older adults often suffer from chronic diseases that require long-term medication adherence.
According to the Italian Institute for International Political Studies, Italy is experiencing rapid population aging, with 37 people older than 65 years per every 100 working-age individuals in 2022. This number is projected to rise to 65 by 2050.
In addition, the share of people over 80 years is expected to increase from 3.7% to 7.5% during the same period, emphasizing the need for effective treatment mechanisms to address the healthcare needs of the elderly.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Perfusion Systems Market Scope
Perfusion Systems Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Medtronic PLC | View profile | 95,000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | www.medtronic.com |
| Getinge AB ADR | View profile | 11,862 | Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 | www.getinge.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| Spectrum Brands Holdings Inc | View profile | 3,100 | 3001 Deming Way, Middleton, WI, United States, 53562 | www.spectrumbrands.com |
| Nipro Corp | View profile | 39,713 | 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 | www.nipro.co.jp |
| LivaNova PLC | View profile | 2,900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | www.livanova.com |
| Repligen Corp | View profile | 1,783 | 41 Seyon Street, Building 1, Suite 100, Waltham, MA, United States, 02453 | www.repligen.com |
| Fresenius Medical Care AG | View profile | 119,845 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | www.freseniusmedicalcare.com |
| Xvivo Perfusion AB | View profile | 130 | Gemenskapens gata 9, Mölndal, Sweden, SE-431 53 | www.xvivoperfusion.com |
Italy Perfusion Systems Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Perfusion Systems Market Outlook will help companies and investors design strategic landscapes.
Cardiopulmonary Perfusion System was the largest segment with a revenue share of 44.4% in 2023.
Horizon Databook has segmented the Italy perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Italy’s aging population and the growing proportion of individuals aged over 65 years are some of the key factors expected to drive the perfusion systems market. This demographic shift is significant as older adults often suffer from chronic diseases that require long-term medication adherence.
According to the Italian Institute for International Political Studies, Italy is experiencing rapid population aging, with 37 people older than 65 years per every 100 working-age individuals in 2022. This number is projected to rise to 65 by 2050.
In addition, the share of people over 80 years is expected to increase from 3.7% to 7.5% during the same period, emphasizing the need for effective treatment mechanisms to address the healthcare needs of the elderly.
- Italy Perfusion Systems Market Application Outlook (Revenue, USD Million , 2018-2030)
- Cardiopulmonary Perfusion System
- Cell Perfusion System
- Ex-Vivo Organ Perfusion System
Reasons to subscribe to Perfusion Systems Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Perfusion Systems Market Outlook databook
- Our clientele includes a mix of Perfusion Systems Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Perfusion Systems Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Perfusion Systems Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Italy Perfusion Systems Market, 2018-2030 (US$M)
Italy perfusion systems market statistics, by application, 2018-2030 (US$M)
